Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Greicius

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Neuron|February 1, 2024
APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer's disease pathologyAugustine Chemparathy, Yann Le Guen, Sunny Chen, et al.
Molecular Neurodegeneration|January 3, 2024
Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's diseaseLihua Wang, Niko-Petteri Nykänen, Daniel Western, et al.
Science (New York, N.Y.)|June 13, 2015
BRAIN NETWORKS. Correlated gene expression supports synchronous activity in brain networksJonas Richiardi, Andre Altmann, Anna-Clare Milazzo, et al.
Nature Neuroscience|March 28, 2024
TREM1 disrupts myeloid bioenergetics and cognitive function in aging and Alzheimer disease mouse modelsEdward N Wilson, Congcong Wang, Michelle S Swarovski, et al.
Nature|December 6, 2023
Organ aging signatures in the plasma proteome track health and diseaseHamilton Se-Hwee Oh, Jarod Rutledge, Daniel Nachun, et al.
Alzheimer'S Research & Therapy|November 12, 2022
Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's diseaseEdward N Wilson, Christina B Young, Javier Ramos Benitez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2024
Plasma Aβ<sub>42</sub>/Aβ<sub>40</sub> is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrumAlexandra N Trelle, Christina B Young, Hillary Vossler, et al.
Nature Genetics|November 11, 2024
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer's diseaseDaniel Western, Jigyasha Timsina, Lihua Wang, et al.
JAMA Neurology|May 31, 2022
Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer DiseaseYann Le Guen, Michael E Belloy, Benjamin Grenier-Boley, et al.
Nature Genetics|November 21, 2022
Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's diseaseHenne Holstege, Marc Hulsman, Camille Charbonnier, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Neuron|February 1, 2024
APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer's disease pathologyAugustine Chemparathy, Yann Le Guen, Sunny Chen, et al.
Molecular Neurodegeneration|January 3, 2024
Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's diseaseLihua Wang, Niko-Petteri Nykänen, Daniel Western, et al.
Science (New York, N.Y.)|June 13, 2015
BRAIN NETWORKS. Correlated gene expression supports synchronous activity in brain networksJonas Richiardi, Andre Altmann, Anna-Clare Milazzo, et al.
Nature Neuroscience|March 28, 2024
TREM1 disrupts myeloid bioenergetics and cognitive function in aging and Alzheimer disease mouse modelsEdward N Wilson, Congcong Wang, Michelle S Swarovski, et al.
Nature|December 6, 2023
Organ aging signatures in the plasma proteome track health and diseaseHamilton Se-Hwee Oh, Jarod Rutledge, Daniel Nachun, et al.
Alzheimer'S Research & Therapy|November 12, 2022
Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's diseaseEdward N Wilson, Christina B Young, Javier Ramos Benitez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2024
Plasma Aβ<sub>42</sub>/Aβ<sub>40</sub> is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrumAlexandra N Trelle, Christina B Young, Hillary Vossler, et al.
Nature Genetics|November 11, 2024
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer's diseaseDaniel Western, Jigyasha Timsina, Lihua Wang, et al.
JAMA Neurology|May 31, 2022
Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer DiseaseYann Le Guen, Michael E Belloy, Benjamin Grenier-Boley, et al.
Nature Genetics|November 21, 2022
Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's diseaseHenne Holstege, Marc Hulsman, Camille Charbonnier, et al.
Pageof 15